Log in
Log in
Or log in with
GoogleGoogle
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Robert Langer
Age : 73
Public asset : 880,929,170 USD
Country of residence : Unknown
Linked companies : Moderna, Inc. - PureTech Health plc - Abpro Bio Co., Ltd. - Seer, Inc. - N2Tech Co.,Ltd - Abpro Corporation

Biography of Robert Langer 
Founder of 40 different companies, among them: Moderna, Inc., Momenta Pharmaceuticals, Inc. and Seer, Inc. (California), Robert S. Langer is an entrepreneur is Professor at Massachusetts Institute of Technology, Specialists at The Water Initiative LLC and Professor at David H. Koch Institute for Integrative Cancer Research and on the board of 31 other companies. In the past he was Director at Combinent BioMedical Systems, Inc. (he founded the company in 2009), Board Advisor at Celero Systems, Inc. (he founded the company), Chairman-Science Board at US Food & Drug Administration, Member of National Academy of Sciences, Member of National Academy of Engineering, Member of Institute of Medicine, Director at Momenta Pharmaceuticals, Inc., Director at Pervasis Therapeutics, Inc., Director at DNIB Unwind, Inc., Director at Semprus BioSciences Corp., Director at Selecta Biosciences, Inc., Director at Kala Pharmaceuticals, Inc., Director at SQZ Biotechnologies Co., Director at Microchips Biotech, Inc., Director at T2 Biosystems, Inc., Director at Lyra Therapeutics, Inc., Director at Tarveda Therapeutics, Inc. and Director at Sigilon Therapeutics, Inc. Robert S. Langer received an undergraduate degree from Cornell University and a doctorate from Massachusetts Institute of Technology.


Current positions of Robert Langer 
Holdings of Robert Langer 
Robert Langer : Personal Network 
Most Read News 
11/28Buffett's Berkshire countersues billionaire Haslams in battle over Pilot valuation
RE
11/30Tesla to deliver Cybertrucks after Musk tempers expectations
MR
11/28Charlie Munger, the 'Oracle of Pasadena' who was Buffett's second-in-command
RE
12/07Elon Musk appeals dispute over SEC consent decree to US Supreme Court
RE
11/27Elon Musk, Netanyahu tour ruins of Israeli kibbutz
RE
11/28Berkshire Hathaway vice chairman Charlie Munger dies at 99
RE
12/06Musk's SpaceX approaches investors for another tender offer - Bloomberg News
RE
11/26Germany's Kuehne examines offer for Signa's Hamburg skyscraper -report
RE
12/07Column-The next big thing in retirement benefits might be the oldest: a traditional pension
RE
12/08Spotify: punished after CFO's departure
CF
More news


© 2023 People and Ownership :   
Robert Langer : Connections 


Latest news about Robert Langer 
10/24Transcript : Alexandria Real Estate Equities, Inc., Q3 2023 Earnings Call, Oct 24, 2023
CI
06/21DarÃę Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1/2 Open-Label Safety and Pharmacokinetics Study of DARE-HRT1 in Healthy Postmenopausal Women
CI
02/13Frequency Therapeutics, Inc. Appoints Christopher Loose, Ph.D., as Interim Chief Executive Officer
CI
01/26Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1 Trial of DARE-HRT1 that Support the Potential of DARE-HRT1 as an Effective Hormone Therapy for both Vasomotor and Vaginal Symptoms of Menopause
CI
01/12Transcript : Establishment Labs Holdings Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-12-2023 07:30 AM
CI
01/09Daré Bioscience, Inc. Announces Positive Pharmacokinetic Results from the DARE-HRT1 Phase 1 / 2 Study
CI
2022Transcript : Establishment Labs Holdings Inc., Q3 2022 Earnings Call, Nov 07, 2022
CI
More news

As early as today, start finding the best investment opportunities!Optimize my profits
Optimize my profits